Skip to main content

Cambridge Trust Co

SEC CIK
0001074272
Latest filing
May 30, 2024

ABBV holding history

AbbVie Inc. in every 13F filed by Cambridge Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q1 2024 holdings

Shares (Q1 2024)
25,253
Value
$4.60M
% of portfolio
0.2%
Quarters held
13
Since Q1 2021
Holdings of ABBV by Cambridge Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 202425,253$4.60M0.2%−2,566−9.2%ReducedHolders
Q4 202327,819$4.31M0.2%+119+0.4%AddedHolders
Q3 202327,700$4.13M0.2%−2,508−8.3%ReducedHolders
Q2 202330,208$4.07M0.2%−3,446−10.2%ReducedHolders
Q1 202333,654$5.36M0.3%−2,118−5.9%ReducedHolders
Q4 202235,772$5.78M0.3%+1,659+4.9%AddedHolders
Q3 202234,113$4.58M0.2%−1,132−3.2%ReducedHolders
Q2 202235,245$5.40M0.2%−1,598−4.3%ReducedHolders
Q1 202236,843$5.97M0.2%−2,138−5.5%ReducedHolders
Q4 202138,981$5.28M0.2%+2,829+7.8%AddedHolders
Q3 202136,152$3.90M0.1%−75−0.2%ReducedHolders
Q2 202136,227$4.08M0.2%−1,222−3.3%ReducedHolders
Q1 202137,449$4.05M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.